Jens Christian Djurhuus Selected Research

Diurnal Enuresis (Daytime Wetting)

9/2017	No immediate effect on urodynamic parameters during transcutaneous electrical nerve stimulation (TENS) in children with overactive bladder and daytime incontinence-A randomized, double-blind, placebo-controlled study.
10/2009	Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens Christian Djurhuus Research Topics

Disease

10	Ureteral Obstruction 01/2012 - 07/2004
3	Overactive Urinary Bladder (Overactive Bladder) 09/2017 - 10/2009
3	Nocturia 08/2015 - 08/2004
3	Acidosis 12/2009 - 08/2008
3	Hydronephrosis 01/2009 - 06/2004
2	Diurnal Enuresis (Daytime Wetting) 09/2017 - 10/2009
2	Enuresis 01/2017 - 06/2008
2	Parkinson Disease (Parkinson's Disease) 12/2015 - 10/2015
2	Nocturnal Enuresis (Bedwetting) 10/2009 - 06/2008
2	Polyuria 06/2008 - 12/2007
1	Fibrosis (Cirrhosis) 01/2021
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2021
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2021
1	Lower Urinary Tract Symptoms 02/2018
1	Prostatic Neoplasms (Prostate Cancer) 02/2018
1	Urinary Calculi (Urinary Calculus) 01/2011
1	Sleep Deprivation 08/2010
1	Urge Urinary Incontinence (Urge Incontinence) 10/2009
1	Body Weight (Weight, Body) 01/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2004
4	AcidsIBA 01/2012 - 08/2008
4	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2009 - 08/2004
3	SodiumIBA 08/2010 - 07/2004
3	Aquaporins (Water Channels)IBA 01/2009 - 07/2004
3	Arginine Vasopressin (Argipressin)IBA 06/2008 - 09/2006
2	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 02/2006
2	Epidermal Growth Factor (EGF)IBA 01/2009 - 01/2006
2	Hormones (Hormone)IBA 09/2006 - 02/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	TeaIBA 08/2015
1	melamineIBA 01/2011
1	PowdersIBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	salicylhydroxamic acid (SHAM)IBA 12/2009
1	Bumetanide (Bumex)FDA LinkGeneric 12/2009
1	Sodium-Hydrogen ExchangersIBA 12/2009
1	AnionsIBA 12/2009
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2009
1	Messenger RNA (mRNA)IBA 01/2009
1	Protein Isoforms (Isoforms)IBA 01/2009
1	Vasopressins (Vasopressin)IBA 06/2008
1	candesartanIBA 02/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2007
1	Urea (Carbamide)FDA LinkGeneric 01/2007
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2007
1	alpha-MSHIBA 02/2006
1	Carrier Proteins (Binding Protein)IBA 06/2004

Therapy/Procedure

3	Transcutaneous Electric Nerve Stimulation (TENS) 09/2017 - 10/2009
2	Radiotherapy 01/2021 - 02/2018
2	Vagotomy 12/2015 - 10/2015
1	Prostatectomy (Retropubic Prostatectomy) 02/2018
1	Therapeutics 01/2017
1	Oral Administration 12/2009